← Browse by Condition
Medical Condition
myocardial fibrosis
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2
ClinicalMetric tracks all active clinical trials for myocardial fibrosis sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — myocardial fibrosis Clinical Trials
How many clinical trials are currently recruiting for myocardial fibrosis?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for myocardial fibrosis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for myocardial fibrosis?
myocardial fibrosis research spans Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a myocardial fibrosis clinical trial?
Eligibility criteria for myocardial fibrosis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2 1
Top Sponsors
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT07296081
Recruiting
⁶⁸Ga-FAPI PET/CT for Cardiac Fibrosis in Heart Failure
Enrollment
30 pts
Location
Portugal
Sponsor
University of Coimbra
NCT06655480 Phase 2
Recruiting
Triple Combination Therapy (ARNI, SGLT2i, MRA) in Advanced HFpEF
Enrollment
50 pts
Location
Russia
Sponsor
National Medical Research Cent...
NCT02670031
Recruiting
Response of the Myocardium to Hypertrophic Conditions in the Adult Population
Enrollment
2,000 pts
Location
Singapore
Sponsor
National Heart Centre Singapor...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology